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Introduction 
Globally, chronic kidney disease (CKD) is an important 
health challenge with an alarming increase in incidence 
as well as prevalence  [1]. CKD patients have a lower 
survival rate, and no significant improvement has been 
achieved on their survival over the past two decades [2].
In Iran, unlike some other countries, hemodialysis (HD) 
is the main way of renal replacement therapy in end 
stage renal disease (ESRD) patients  [3]. Limited stud-
ies have been conducted in Iran regarding the survival 
of HD patients, suggesting a low survival rate for these 
patients [4, 5].
Common independent predictors of survival in HD pa-
tients are: age, race, albumin and hemoglobin levels, 
etiology of kidney failure and presence of certain co-
morbidities  [3, 6-9]. Apart from these accepted prog-
nostic factors, the role of some factors such as dialysis 
frequency is controversial on morbidity and mortality 
among hemodialysis patients [10].
In general, the interaction occurs when the effect of one 
risk factor is dependent on the presence of another risk 
factor  [11]. When resources are limited, assessing in-
teractions provides insight into the mechanisms for the 
outcome and identifying subgroups would benefit most 
from interventions [11, 12]. Interactions between some 
variables like three-way interaction between protein-
energy wasting (PEW), inflammation and cardiovascu-
lar diseases (CVD)  [13], interaction between albumin 
and phosphor  [14] and three-way interaction between 
BMI, physical activity and smoking [15] on HD patients 
survival were shown previously. However, the lack of 
knowledge in this regard is still high.
Identification of survival modifiable factors and interac-
tions between them could help in prioritizing the clinical 
care of HD patients. Evidences regarding the survival 
rate of hemodialysis patients in developing countries 
are rare and most of these studies were conducted in de-
veloped countries where patients have more access to 
health cares, and their results cannot be generalized to 
developing countries. Therefore, in the present study, we 
aimed to investigate the survival rate and it`s correlates 




We performed a retrospective cohort study to investigate 
predictors of mortality among hemodialysis patients.
Study settings 
We examined data on 758 patients who underwent he-
modialysis treatment in Hamadan province in western 
Iran from March 2007 to March 2017. Hamadan prov-
ince, with an area of 19,493 square kilometers in extent, 
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is located in western Iran. According to the national cen-
sus held by the Statistical Center of Iran, Hamadan prov-
ince had a population of 1,758,268 people in 2011. We 
used information of patients from eight hospitals in the 
province with a dialysis wards, including: Alimoradian, 
Besat, Vali-asr, Ghaem, Imam Hossein, Valiasr, Imam 
Reza, and Shahid-Beheshti in Nahavand, Hamadan, 
Tuyserkan, Asadabad, Malayer, Razan, Kabudarahang 
and Hamadan city, respectively. 
Eligibility criteria
All ESRD patients who initiated chronic hemodialysis 
programs at the dialysis units of the above mentioned 
hospitals during 2007 to 2017 were considered as inclu-
sion criteria. Patients with acute renal failure or under 
treatment with peritoneal dialysis, patients on transient 
hemodialysis and patients with incomplete medical re-
cords were excluded from study.
Clinical and demographic measures
Data were gathered by a checklist on hospital records 
of all HD patients in the province. The checklist used in 
this study included characteristics related to demograph-
ic profiles (age (year), gender (male, female), marital 
status (married, single, divorce, widow), BMI (kg/m2), 
residence area (urban, rural), educational level (illiter-
ate, primary, guidance, high school, academic), the his-
tory of tobacco use (yes, no) and substance abuse (yes, 
no)), and clinical information (including Hemoglobin 
(g/dl), BUN (mg/dL), Creatinine (mg/dL), CRP status 
(positive, negative), Sodium (mEq/L), Calcium (mg/
dL), Phosphor (mg/dL), iPTH (pg/ml), Albumin (g/dl) 
and ESRD cause (Hypertension, Diabetes, Urologic& 
obstructive diseases, Polycystic Kidney, Glomerulone-
phritis, Un-Known)). The clinical and laboratory infor-
mation of patients at the beginning of their treatment 
and before receiving the first dialysis treatment was 
gathered. In order to minimize measurement variability, 
all two baseline measures (two last measurements be-
fore the first dialysis treatment) for each patient were 
averaged. These records were collected by reviewing pa-
tients’ medical records.
Outcome
We considered the end point of the patients’ follow up as 
their death. The survival time was the time between the 
start of HD treatment to patients death. Patients with re-
nal transplantation, or withdrawal of dialysis, or unable 
to follow them due to transferred another dialysis facil-
ity out of province as well as, patients who died because 
of injury or accident, or other causes unrelated to renal 
failure were considered as censored cases. 
Statistical analysis
We utilized the random survival forest (RF) method that 
ensembles binary decision trees and extends the RF re-
gression model to right-censored survival data. In this 
technique, a random bootstrap sample (containing two 
thirds of the original data on average) is drawn for every 
decision tree. Thus, the remaining one third of the data 
known as out-of-bag (OOB) data is excluded. Decision 
trees are grown based on the bootstrap samples by ap-
plying a random node splitting process which works as 
follows: At each node random candidate variables (mtry 
determined by the square root of the total number of 
variables) are selected for random node splitting. Then 
the variable that maximizes the survival differences be-
tween two daughter nodes (determined by a splitting 
rule like the log-rank statistic) for a special split point 
is selected for node splitting. The growth of a decision 
tree is stopped when all the terminal nodes contain only 
a predefined minimal number of unique events. 
To comparison, the stepwise Cox proportional hazards 
model was used. So, the Harrell’s concordance index 
(C-index) criterion was utilized  [16] using out-of-bag 
(OOB) data. The minimal depths of the covariates were 
obtained to select predictive variables. Minimal depth is 
a dimensionless order statistic that measures the predic-
tiveness of a variable in a tree. It can be used to select 
variables in high-dimensional problems. It assesses the 
predictiveness of a variable by a depth calculation rela-
tive to the root node of a tree. The smaller the minimal 
depth, the more predictive the variable. 
Analyses were performed by using “randomForest-
SRC”, a freely available package from the Comprehen-
sive R Archive Network (CRAN).
Results
Descriptive statistics of the characteristics of the pa-
tients were presented in Tab. I. According to the table, 
the majority of the patients were male (54.9%), married 
(79.1%), non-smoker (76.7%), non-substance abused, il-
literate (54.9%) and lived in rural area (65.6%). About 
47.8% of the patients experienced death. The median 
survival time was 613 days. The mean and standard de-
viation of other variables were reported in Table I. 
Figure 1 shows the minimal depth of the variables ob-
tained from RSF. According to the figure, hemoglobin, 
CRP, albumin, age at diagnosis and iron were highly 
predictive and URR, uric acid, dialysis weekly time, 
PLT, Na, P, Ca, K, HCT, ALK and vascular access were 
moderately predictive. Moreover, other used variables 
were unlikely to be predictive. According to the stepwise 
Cox PH model, the variables of age at diagnosis, mar-
riage status, BMI, addiction, hemoglobin, iron, albumin 
and CRP were selected as the most important variables 
(Tab. II). The performance of the RSF was assessed us-
ing Harrel’s C-index and compared with the stepwise 
Cox PH. According to the results, the RSF had a higher 
c-index (0.808) compared with the Cox model (0.727).
The effects of the most four influential variables found 
in the RSF with 5-year partial survival plots analysis 
were demonstrated in Figure 2. The estimated partial 
survival for a variable shows the estimated survival for 
different levels of the variable when the effects of all 
other variables are justified. For example, patients with 
negative CRP shower a higher 5-year predicted survival 
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compared with those with positive CRP. The non-linear 
nature of the selected variables is evident from the fig-
ure. For example, as hemoglobin increases up to about 
10 (g/dl (the five-year predicted survival increases very 
slightly and it tends to increase dramatically after that 
point up to.
Figure 3  displays interaction between the three im-
portant variables of CRP, hemoglobin, and Albumin 
on 5 year predicted survival. Patients with positive 
CRP and hemoglobin values lower than 11 have the 
worst survival (see the first row, second column) and 
most had low albumin. Survival was best for patients 
Fig. 1. Minimal depth of variables affecting survival of HD patients obtained using random survival forest. 
Tab. I. Descriptive statistics of characteristics related to participants.
Variable Frequency (%) Variable Frequency (%)/Mean (SD)
Gender ESRD cause
Male 431 (54.9) Hypertension 222 (28.3)
Female 354 (45.1) Diabetes 193 (24.6)
Marital status Urologic& obstructive diseases 75 (9.6)
Married 621 (79.1) Polycystic Kidney 35 (4.5)
Single 81 (10.3) Glomerulonephritis 56 (7.1)
Divorce 11 (1.4) Diabetes and Hypertension 79 (10.1)
Widow 72 (9.2) Unknown -
The history of tobacco use 
Yes 183 (23.3) BMI (kg/m2) 23.10 (3.97)
No 602 (76.7) Hemoglobin (g/dl) 10.49 (1.92)
Substance abuse Creatinine (mg/dL) 7.85 (3.18)
Yes 121 (15.4) Sodium (mEq/L) 138.88 (7.24)
No 664 (84.6) Calcium (mg/dL) 8.71 (0.86)
Residence area Phosphor (mg/dL) 5.11 (1.58)
Urban 487 (62) Iron 99.89 (97.58)






Primary school 229 (29.2)
High school 114 (14.5)
Academic 27 (3.4)
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Tab. II. The results of stepwise Cox proportional Hazards in selecting predictors affecting survival time of HD patients in Hamadan Province 
from 2007 to 2017.
Variables B SE P.Value Exp(B) 95% CI for Exp(B)
Lower Upper
Age at diagnosis -0.023 0.006 < 0.001 0.977 0.966 0.988
Marriage status Married 1.000
Single -1.423 0.615 0.021 0.241 0.072 0.804
Divorce -0.174 0.464 0.707 0.840 0.338 2.085
Widow 0.308 0.486 0.526 1.361 0.525 3.525
Location Urban 1.000
Rural -0.220 0.110 0.046 0.803 0.647 0.996
BMI status < 18.5 kg/m2 1.000 0.010
18.5-25 kg/m2 1.000 0.303 0.001 2.719 1.500 4.926
25-30 kg/m2 0.663 0.250 0.008 1.941 1.190 3.165
> 30 kg/m2 0.740 0.265 0.005 2.096 1.247 3.523
Addiction Yes 1.000
No -0.326 0.136 0.017 0.722 0.552 0.942
Hemoglobin -0.203 0.030 < 0.001 0.816 0.769 0.866
Iron -0.003 0.001 < 0.001 0.997 0.996 0.999
Albumin -0.421 0.070 < 0.001 0.656 0.572 0.753
CRP -1.157 0.119 < 0.001 0.314 0.249 0.397
Fig. 2. Partial 5-year predicted survival for four most influential variables on survival in HD data. Dashed red lines are ± 2 standard error bars 
(red dots indicates the estimated survival at the observed levels of each correlate and the black hatches are the smoothed curves based on 
the loess curves for the estimated survival for each individual.
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with negative CRP and hemoglobin ≥ 11 (see second 
row, first column) and further dependent on changes 
in albumin. 
In this group the 5 years predicted survival was over 
70% for those with albumin values greater than 4, but 
only about 50% for those with albumin of 1 (g/dl). It 
is important to note that these interactions and non-
linear relationships were identified by the random 
survival forest, and not prespecified by the analyst. 
The median survival time in the two categories of low 
Hemoglobin/positive CRP and high Hemoglobin/neg-
ative CRP were 5.38 and 40.53 months, respectively.
Discussion 
Hemodialysis is a common treatment modality for ESRD 
patients in Iran. In this study we investigated the predic-
tors of survival in HD patients. The findings of this study 
can be used to improve quality of cares provided for the 
HD patients and better resource allocation. We found 
that hemoglobin level, albumin level, and CRP status 
were the top three most important predictors of survival 
for HD patients in the present study.
Along with the results of this study, the role of low 
hemoglobin level in increasing the risk of mortality in 
Fig. 3. Random survival forest estimated five-year survival as a function of CRP, Hemoglobin, and Albumin. Smoothed curves are loess 
curves of the estimated survival for each individual.
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HD patients has been shown in previous studies [17, 18]. 
Anemia is one of the main risk factors in the develop-
ment of left ventricular hypertrophy (LVH), and con-
sequence cardiac mortality and morbidity in ESRD pa-
tients  [19]. Early management of anemia is associated 
with reduction in the severity of comorbid conditions 
and can slow the progression to renal failure [20]. Robert 
et al. showed that normalization of hemoglobin through 
preventing the development of LV dilation, leads to im-
proved quality of life of HD patients [21].
In agreement with our finding, other studies results in-
dicated that low serum albumin is one of the main pre-
dictors of poor survival in HD patients [22, 23]. Hypo-
albuminemia usually considered as the proxy of malnu-
trition. Mafra et al. in a Brazilian cohort of hemodialysis 
patients found that both low BMI and hypo-albuminemia 
are strong predictors of death [24]. Combe et al. showed 
that a decrease in serum albumin over time correlated 
with increased CVD death [25]. 
One of the other main predictors of mortality in HD pa-
tients in this study was CRP status. Similar findings have 
been obtained in other studies  [26, 27]. Lseki et al. in 
their study showed that regardless of serum albumin and 
other possible confounders, CRP is a significant predic-
tor of death in HD patients [28]. Inflammation usually is 
in relation with insulin resistance, oxidative stress, wast-
ing, infections and endothelial dysfunction [29].
Interactions between some modifiable variables on sur-
vival of HD patients were seen previously [13, 15]. We 
found that the combined effect of CRP status with serum 
Hemoglobin and CRP status has the significant effect 
on the survival of HD patients. This finding is important 
because HD patients with a high mortality risk can be 
identified through regular screening. More studies are 
needed to determine multiple pathophysiological path-
ways may underlie these combined effects.
This study had some limitations as well. First, because 
of the retrospective design of the study, verifying quality 
control of the data was not possible. Second, the addic-
tion and smoking status of patients was based on their 
self-report and therefore was prone to information bias 
and finally quality of the services and technology may 
vary over time, and also the quality of service provision 
in the dialysis wards of hospitals is not the same, which 
could not be considered in this study. Despite these limi-
tations there was strength for this study which was the 
utilization of the RSF to analyze the data set. RSF can 
handle the issues with the traditional Cox model like 
proportionality assumption automatically. This will help 
analysts to deal with the relationships (i.e. linear, non-
linear) between variables over time without any previous 
knowledge.
Conclusions
We found that higher levels of CRP, low serum albumin 
and low serum hemoglobin were the top three most im-
portant predictors of poor survival for HD patients.
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